Et- hundrede patienter blev oprindeligt behandlet med Kaletra i forsøget (inkluderende 51 patienter, der modtog 400/ 100 mg to gange daglig og 49 patienter på enten 200/ 100 mg to gange daglig eller 400/ 200 to gange daglig).
One hundred patients were originally treated with Kaletra in the study (including 51 patients receiving 400/ 100 mg twice daily and 49 patients at either 200/ 100 mg twice daily or 400/ 200 mg twice daily).